Clorox (NYSE:CLX) Price Target Raised to $171.00

Clorox (NYSE:CLX) had its price target raised by DA Davidson from $153.00 to $171.00 in a research report sent to investors on Monday morning, Benzinga reports. DA Davidson currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox’s Q2 2025 earnings at $1.27 EPS and FY2026 earnings at $6.61 EPS.

CLX has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $155.00.

Clorox Price Performance

Shares of NYSE:CLX opened at $162.70 on Monday. The firm has a 50 day moving average of $161.89 and a 200-day moving average of $146.58. The stock has a market capitalization of $20.14 billion, a PE ratio of 56.69, a PEG ratio of 3.11 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. Clorox has a 12 month low of $127.60 and a 12 month high of $169.09.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 EPS. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that Clorox will post 6.81 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. Clorox’s dividend payout ratio is currently 170.03%.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Clorox

Several large investors have recently made changes to their positions in the business. Innealta Capital LLC acquired a new position in Clorox in the 2nd quarter worth about $30,000. Trifecta Capital Advisors LLC raised its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares during the last quarter. First Foundation Advisors bought a new stake in Clorox during the 1st quarter worth about $31,000. Family Firm Inc. bought a new position in Clorox in the 2nd quarter valued at $31,000. Finally, Quarry LP grew its position in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.